Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Porcine Epidemic Diarrhea Virus Infection Inhibits Interferon Signaling by Targeted Degradation of STAT1.

Guo L, Luo X, Li R, Xu Y, Zhang J, Ge J, Bu Z, Feng L, Wang Y.

J Virol. 2016 Aug 26;90(18):8281-92. doi: 10.1128/JVI.01091-16. Print 2016 Sep 15.

3.

Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.

Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.

MAbs. 2010 Jan-Feb;2(1):53-66. Epub 2010 Jan 27.

4.

Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses.

Prabakaran P, Zhu Z, Xiao X, Biragyn A, Dimitrov AS, Broder CC, Dimitrov DS.

Expert Opin Biol Ther. 2009 Mar;9(3):355-68. doi: 10.1517/14712590902763755 . Review. Erratum in: Expert Opin Biol Ther. 2009 Apr;9(4):533.

5.

Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).

Suresh MR, Bhatnagar PK, Das D.

J Pharm Pharm Sci. 2008 Apr 19;11(2):1s-13s.

6.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Review.

7.
8.

Animal models and vaccines for SARS-CoV infection.

Roberts A, Lamirande EW, Vogel L, Jackson JP, Paddock CD, Guarner J, Zaki SR, Sheahan T, Baric R, Subbarao K.

Virus Res. 2008 Apr;133(1):20-32. Epub 2007 May 11.

9.

Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS.

Zhao J, Wang W, Wang W, Zhao Z, Zhang Y, Lv P, Ren F, Gao XM.

Clin Vaccine Immunol. 2007 Jul;14(7):839-46. Epub 2007 May 2.

10.

Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.

Haynes LM, Miao C, Harcourt JL, Montgomery JM, Le MQ, Dryga SA, Kamrud KI, Rivers B, Babcock GJ, Oliver JB, Comer JA, Reynolds M, Uyeki TM, Bausch D, Ksiazek T, Thomas W, Alterson H, Smith J, Ambrosino DM, Anderson LJ.

Clin Vaccine Immunol. 2007 Mar;14(3):331-3. Epub 2007 Jan 17.

12.

Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Li W, Wong SK, Li F, Kuhn JH, Huang IC, Choe H, Farzan M.

J Virol. 2006 May;80(9):4211-9. Review. No abstract available.

13.
14.
15.

Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus.

Lip KM, Shen S, Yang X, Keng CT, Zhang A, Oh HL, Li ZH, Hwang LA, Chou CF, Fielding BC, Tan TH, Mayrhofer J, Falkner FG, Fu J, Lim SG, Hong W, Tan YJ.

J Virol. 2006 Jan;80(2):941-50.

16.

SARS-CoV genome polymorphism: a bioinformatics study.

Pavlović-Lazetić GM, Mitić NS, Tomović AM, Pavlović MD, Beljanski MV.

Genomics Proteomics Bioinformatics. 2005 Feb;3(1):18-35.

18.

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.

Temperton NJ, Chan PK, Simmons G, Zambon MC, Tedder RS, Takeuchi Y, Weiss RA.

Emerg Infect Dis. 2005 Mar;11(3):411-6.

19.

Amino acids 1055 to 1192 in the S2 region of severe acute respiratory syndrome coronavirus S protein induce neutralizing antibodies: implications for the development of vaccines and antiviral agents.

Keng CT, Zhang A, Shen S, Lip KM, Fielding BC, Tan TH, Chou CF, Loh CB, Wang S, Fu J, Yang X, Lim SG, Hong W, Tan YJ.

J Virol. 2005 Mar;79(6):3289-96.

20.

Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.

Chen Z, Zhang L, Qin C, Ba L, Yi CE, Zhang F, Wei Q, He T, Yu W, Yu J, Gao H, Tu X, Gettie A, Farzan M, Yuen KY, Ho DD.

J Virol. 2005 Mar;79(5):2678-88.

Supplemental Content

Support Center